WMSA
MDCO

Weiss Multi-Strategy Advisers’s Medicines Co MDCO Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio MDCO Stock Details MDCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-204,577
Closed -$17.4M – 719
2019
Q4 		$17.4M Buy
+204,577
New +$13.6M 0.28% 105
2019
Q3 		– Sell
-35,000
Closed -$1.4M – 746
2019
Q2 		$1.28M Buy
35,000
+10,000
+40% +$326K 0.03% 357
2019
Q1 		$699K Buy
25,000
+1,500
+6% +$35.4K 0.02% 418
2018
Q4 		$450K Buy
+23,500
New +$547K 0.02% 359
2015
Q4 		– Sell
-11,000
Closed -$418K – 482
2015
Q3 		$418K Buy
+11,000
New +$386K 0.02% 332
2014
Q2 		– Sell
-7,160
Closed -$203K – 1015
2014
Q1 		$203K Buy
7,160
+1,330
+23% +$44K ﹤0.01% 915
2013
Q4 		$225K Sell
5,830
-2,540
-30% -$90.8K ﹤0.01% 882
2013
Q3 		$281K Buy
+8,370
New +$267K 0.01% 661

Other funds holding MDCO

GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Weiss Multi-Strategy Advisers's MDCO Position: Q1 2020 in Review

Weiss Multi-Strategy Advisers sold out of Medicines Co (MDCO) in Q1 2020, closing a stake of 204,577 shares — an estimated $17.4M sold.

Weiss Multi-Strategy Advisers first reported a position in MDCO in Q3 2013 and held it in 8 quarters. The position peaked at $17.4M in Q4 2019. 1 fund tracked by Wall St. Rank holds MDCO as of Q1 2020.

  • Weiss Multi-Strategy Advisers reported no remaining Medicines Co position as of Q1 2020 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 204,577 Medicines Co shares in Q1 2020, an estimated $17.4M.
  • Weiss Multi-Strategy Advisers first reported a position in Medicines Co in Q3 2013 and held it in 8 quarters.
  • Weiss Multi-Strategy Advisers's Medicines Co position peaked at $17.4M in Q4 2019.
  • 1 fund tracked by Wall St. Rank held Medicines Co as of Q1 2020.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q1 2020, filed 15 May 2020.